...in the news

Displaying 881 - 890 of 1080 (10 per page)

Score	HS	BSN	CLB	EQT	IPO	M&A	IP	Date
								Jan 18, 2017
Synthomics Announces Completion Of Seed Financing And Launch Of Early Access Program For Next-generation DNA Synthesis Platform
								Jun 15, 2016
Rgenix Raises $33M, Preps Cancer Trial for Drug Shelved by GSKller University by three brothers, has reeled in a $33 million Series B financing as it preps its top drug candidate, a cancer immunotherapy agent, to enter clinical trials. the drug, known as
								Aug 31, 2015
In New York, Rgenix Rises from Rockefeller and Takes Aim at Cancer
								Aug 4, 2016
Ambrx closes $45M round of financing
								Nov 17, 2016
Apama Medical Closes $19.5M in Series C Equity and Debt Financing, Presents First in Human Data At AHA's Scientific Sessions 2016
								Sep 16, 2016
Seattle's Sound Pharmaceuticals raising $30M to advance trials of hearing-loss drug
								Jun 28, 2016
UQM Technologies Executes on Its China Expansion Strategy with Announcement of Definitive Agreement with Hybrid Kinetic Group Limited to Invest $48 Million in UQM
								Apr 26, 2016
BioFactura Closes Oversubscribed $1.8M Series A Funding led by Chairman of the Board Dr. Jeffrey Hausfeld
								Jul 23, 2015
SutroVax, a South San Francisco, CA-based biopharmaceutical vaccine company, completed a $22m Series a financing.
								Mar 6, 2017
Exclusive: TechAccel Joins Epicrop $3m Series a to Develop Novel Epigenetics Tools for Crop Enhancement